Keros Therapeutics, Inc.KROSNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank71
3Y CAGR+5.2%
5Y CAGR+74.6%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+5.2%/yr
vs -6.2%/yr prior
5Y CAGR
+74.6%/yr
Recent deceleration
Acceleration
+11.4pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
16.2x
Strong expansion
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.06 | +68.8% |
| 2024 | 0.03 | -24.1% |
| 2023 | 0.04 | -9.1% |
| 2022 | 0.05 | +963.9% |
| 2021 | 0.00 | +30.9% |
| 2020 | 0.00 | -99.9% |
| 2019 | 2.58 | +4070.2% |
| 2018 | 0.06 | - |